Trials / Completed
CompletedNCT02758041
A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- Sebacia, Inc. · Industry
- Sex
- All
- Age
- 16 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study is proposed to evaluate Sebacia Microparticle treatment in patients with facial inflammatory acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sebacia Microparticles |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-01-01
- Completion
- 2017-02-01
- First posted
- 2016-05-02
- Last updated
- 2017-09-07
Locations
3 sites across 2 countries: Denmark, Switzerland
Source: ClinicalTrials.gov record NCT02758041. Inclusion in this directory is not an endorsement.